日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease

指导性降脂临床试验对当代真实世界中患有动脉粥样硬化性心血管疾病患者的适用性

Schuitema, Pauline C E; Stam-Slob, Manon C; Visseren, Frank L J; Koopal, Charlotte

Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review

双磷酸甘油酸变位酶缺乏症杂合子临床表现为先天性红细胞增多症:病例系列及文献综述

van Dijk, Myrthe J; van Oirschot, Brigitte A; Stam-Slob, Manon C; Waanders, Esmé; van der Zwaag, Bert; van Beers, Eduard J; Jans, Judith J M; van der Linden, Peter Willem; Torregrosa Diaz, Jose M; Gardie, Betty; Girodon, François; Schots, Rik; Thielen, Noortje; van Wijk, Richard

Impact of a Patient's Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making

患者基线风险对预防性治疗策略相对获益和风险的影响:将试验结果应用于临床决策

de Vries, Tamar I; Stam-Slob, Manon C; Peters, Ron J G; van der Graaf, Yolanda; Westerink, Jan; Visseren, Frank L J

Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

基于个体绝对获益的冠状动脉疾病患者强化他汀类药物降脂治疗的成本效益分析

Stam-Slob, Manon C; van der Graaf, Yolanda; Greving, Jacoba P; Dorresteijn, Jannick A N; Visseren, Frank L J

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients

他汀类药物治疗在老年患者血管疾病一级或二级预防中的个体化绝对获益

Stam-Slob, Manon C; Visseren, Frank L J; Wouter Jukema, J; van der Graaf, Yolanda; Poulter, Neil R; Gupta, Ajay; Sattar, Naveed; Macfarlane, Peter W; Kearney, Patricia M; de Craen, Anton J M; Trompet, Stella